LAW PROPOSED IN USA TO HASTEN GENERIC DRUGS APPROVAL
March 1st, 2012 BY LEAH GERMAIN NEW legislation has been proposed in the USA that aims to expedite market approval procedures for generic drugs to reduce the country's growing pharmaceutical drug shortage. The Generic Drug and Biosimilar User Fee Act was introduced into the House of Representatives by Republican Representative Tim Murphy on March 5 with Democrat support and seeks to develop inspections for foreign pharmaceutical manufacturers that reflect domestic controls. According to the US-based trade organisation Bulk Pharmaceuticals Task Force (BPTF), 40% of all drugs ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.